NO20091990L - Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse - Google Patents

Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse

Info

Publication number
NO20091990L
NO20091990L NO20091990A NO20091990A NO20091990L NO 20091990 L NO20091990 L NO 20091990L NO 20091990 A NO20091990 A NO 20091990A NO 20091990 A NO20091990 A NO 20091990A NO 20091990 L NO20091990 L NO 20091990L
Authority
NO
Norway
Prior art keywords
compositions containing
preparation
methods
substituted pyrazoles
pyrazoles
Prior art date
Application number
NO20091990A
Other languages
English (en)
Norwegian (no)
Inventor
Kirsten Bjergarde
Mark Dodson
Jacques Mauger
Anil Nair
Marcel Patek
Michel Tabart
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20091990L publication Critical patent/NO20091990L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20091990A 2006-11-10 2009-05-22 Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse NO20091990L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609812A FR2908409B1 (fr) 2006-11-10 2006-11-10 Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
PCT/FR2007/001851 WO2008065282A2 (fr) 2006-11-10 2007-11-09 Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
NO20091990L true NO20091990L (no) 2009-06-02

Family

ID=38169388

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091990A NO20091990L (no) 2006-11-10 2009-05-22 Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse

Country Status (39)

Country Link
US (3) US7989439B2 (de)
EP (1) EP2091920B1 (de)
JP (1) JP5538893B2 (de)
KR (1) KR20090083456A (de)
CN (1) CN101553473B (de)
AR (1) AR063638A1 (de)
AU (1) AU2007327423B2 (de)
BR (1) BRPI0718999A2 (de)
CA (1) CA2667846A1 (de)
CL (1) CL2007003251A1 (de)
CO (1) CO6190516A2 (de)
CR (1) CR10749A (de)
CY (1) CY1116000T1 (de)
DK (1) DK2091920T3 (de)
DO (1) DOP2009000088A (de)
EA (1) EA019454B1 (de)
EC (1) ECSP099312A (de)
ES (1) ES2528385T3 (de)
FR (1) FR2908409B1 (de)
HN (1) HN2009000856A (de)
HR (1) HRP20150070T1 (de)
IL (1) IL198328A0 (de)
MA (1) MA30972B1 (de)
MX (1) MX2009004983A (de)
MY (1) MY147502A (de)
NI (1) NI200900078A (de)
NO (1) NO20091990L (de)
NZ (1) NZ576709A (de)
PE (2) PE20081162A1 (de)
PL (1) PL2091920T3 (de)
PT (1) PT2091920E (de)
SI (1) SI2091920T1 (de)
SV (1) SV2009003253A (de)
TN (1) TN2009000155A1 (de)
TW (1) TW200829556A (de)
UA (1) UA97965C2 (de)
UY (1) UY30707A1 (de)
WO (1) WO2008065282A2 (de)
ZA (1) ZA200903560B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858323B2 (en) * 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique
UY33200A (es) * 2010-01-26 2011-08-31 Sanofi Aventis Derivados de ácido 3-heteroaroilamino-propiónico sustituidos con oxígeno y su uso como productos farmacéuticos
TWI523844B (zh) * 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之３－雜芳醯基胺基－丙酸衍生物及其作為藥物之用途
CN102432639B (zh) * 2011-09-30 2013-11-06 山东大学 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用
US20150291554A1 (en) 2012-11-02 2015-10-15 Pfizer Inc. Bruton's Tyrosine Kinase Inhibitors
EP3274344B1 (de) * 2015-03-25 2019-04-24 Novartis Ag Formylierte n-heterocyclische derivate als fgfr4-inhibitoren
CN107619388A (zh) * 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
JP2004538266A (ja) * 2001-04-27 2004-12-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド ピラゾール由来のキナーゼインヒビター
RU2005135337A (ru) * 2003-04-16 2006-06-10 Астразенека Аб (Se) Производные хиназолина для лечения злокачественного новообразования
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
EP2256106B1 (de) * 2003-07-22 2015-05-06 Astex Therapeutics Limited 3,4-disubstituierte 1H-Pyrazol-Verbindungen und deren Verwendung als Cyclin-abhängige Kinase (CDK) und Glycogen Synthase Kinase-3 (GSK-3) Modulatoren
JP2008505167A (ja) * 2004-07-05 2008-02-21 アステックス、セラピューティックス、リミテッド 医薬組成物
US20080261952A1 (en) * 2004-08-16 2008-10-23 Jason Bloxham Aryl Urea Derivatives for Treating Obesity
EP1836188A1 (de) * 2004-12-30 2007-09-26 Astex Therapeutics Limited Die aktivität von cdk, gsk und aurora-kinasen modullierende pyrazolderivate
AR052559A1 (es) * 2005-01-21 2007-03-21 Astex Therapeutics Ltd Derivados de pirazol para inhibir cdk's y gsk's
WO2006077425A1 (en) * 2005-01-21 2006-07-27 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors and further antitumor agents
EP1683796A1 (de) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridine, ihre Herstellung und ihre medizinische Verwendung
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CN101553473B (zh) 2013-06-05
US8410286B2 (en) 2013-04-02
MX2009004983A (es) 2009-05-22
JP5538893B2 (ja) 2014-07-02
UA97965C2 (ru) 2012-04-10
TN2009000155A1 (fr) 2010-10-18
FR2908409B1 (fr) 2009-01-09
ES2528385T3 (es) 2015-02-09
BRPI0718999A2 (pt) 2014-02-25
WO2008065282A2 (fr) 2008-06-05
US7989439B2 (en) 2011-08-02
EA019454B1 (ru) 2014-03-31
HRP20150070T1 (hr) 2015-02-27
AR063638A1 (es) 2009-02-04
TW200829556A (en) 2008-07-16
SI2091920T1 (sl) 2015-02-27
CR10749A (es) 2009-07-23
NI200900078A (es) 2010-01-27
US8420824B2 (en) 2013-04-16
KR20090083456A (ko) 2009-08-03
AU2007327423B2 (en) 2012-09-06
PE20081162A1 (es) 2008-10-02
WO2008065282A3 (fr) 2008-07-31
US20090291984A1 (en) 2009-11-26
CN101553473A (zh) 2009-10-07
PT2091920E (pt) 2015-02-05
IL198328A0 (en) 2010-02-17
ECSP099312A (es) 2009-06-30
EA200970472A1 (ru) 2009-10-30
AU2007327423A1 (en) 2008-06-05
CL2007003251A1 (es) 2009-08-07
MA30972B1 (fr) 2009-12-01
CO6190516A2 (es) 2010-08-19
DK2091920T3 (en) 2015-01-26
ZA200903560B (en) 2010-08-25
EP2091920B1 (de) 2014-10-22
HN2009000856A (es) 2011-10-19
US20110237801A1 (en) 2011-09-29
HK1137988A1 (en) 2010-08-13
SV2009003253A (es) 2009-10-27
MY147502A (en) 2012-12-14
JP2010509297A (ja) 2010-03-25
FR2908409A1 (fr) 2008-05-16
NZ576709A (en) 2011-08-26
UY30707A1 (es) 2008-07-03
CA2667846A1 (fr) 2008-06-05
PL2091920T3 (pl) 2015-04-30
CY1116000T1 (el) 2017-01-25
EP2091920A2 (de) 2009-08-26
US20110237641A1 (en) 2011-09-29
PE20121152A1 (es) 2012-09-07
DOP2009000088A (es) 2013-06-15

Similar Documents

Publication Publication Date Title
NO20081013L (no) 7-substituerte aza-indazoler, sammensetninger inneholdende disse, produksjonsmetode og anvendelse derav
NO20083153L (no) Kjemiske forbindelser
NO20090295L (no) Substituerte heteroarylderivater
NO20090628L (no) Pyridizinon derivativater
EA201170772A1 (ru) Органические соединения
DK1888541T3 (da) Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EA201170295A1 (ru) ИНГИБИТОРЫ сМЕТ
NO20071593L (no) Pyrimidinderivater
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
WO2009156462A3 (en) Organic compounds
NO20075647L (no) Kjemiske forbindelser
NO20090596L (no) Antivirale fosfinatforbindelser
AU2009236256A8 (en) Small molecule inhibitors of the pleckstrin homology domain and methods for using same
NO20084850L (no) MGLUR5 modulatorer I
NO20084186L (no) Nye aminer
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
WO2010048358A3 (en) Ethoxyphenylmethyl inhibitors of sglt2
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
NO20085212L (no) Nye pyridinanaloger
ATE500222T1 (de) Benzamid- und heteroarenderivate als cetp- inhibitoren
DK2107055T3 (da) Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
NO20083738L (no) Sekundaere aminer som renininhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application